Filing Details

Accession Number:
0000899243-21-025828
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-24 20:55:41
Reporting Period:
2021-06-22
Accepted Time:
2021-06-24 20:55:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662244 Cyteir Therapeutics Inc. CYT Pharmaceutical Preparations (2834) 455429901
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1864377 Janwillem Naesens 128 Spring St, Building A, Suite 510
Lexington MA 02421
No No Yes No
1867855 Sarl Gp Ii Df 28 Boulevard Joseph Ii
Luxembourg N4 L-1840
No No Yes No
1867886 Luc Verelst 28 Boulevard Joseph Ii
Luxembourg N4 L-1840
No No Yes No
1867904 Bv Wepaven Brusselsesteenweg 11
Meise C9 1860
No No Yes No
1867968 Scsp Ii Invest Droia 28 Boulevard Joseph Ii
Luxembourg N4 L-1840
No No Yes No
1868013 Sa Ihl 28 Boulevard Joseph Ii
Luxembourg N4 L-1840
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-22 3,259,026 $0.00 3,259,026 No 4 C Direct
Common Stock Acquisiton 2021-06-22 277,777 $18.00 3,536,803 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2021-06-22 10,000,000 $0.00 2,933,583 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2021-06-22 1,109,368 $0.00 325,443 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.
  2. Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.